Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
The company offers compounded semaglutide and compounded tirzepatide through a streamlined telehealth model that prioritizes speed, cost transparency, and physician oversight
I look forward to seeing research on the calorie restriction caused by these medications to see if they increase peoples lifespans in the long run. Clifford Segil, DO
Trump Admin Fires Thousands at HHS : The Trump administration terminated nearly 1,300 probationary employees at HHS, including all 50 first-year officers in the CDCs Epidemic Intelligence Service as part of current DOGE initiatives
In 2025, Novo Nordisks semaglutide awaits several first-time FDA decisions: 3Q 2025 the first GLP-1 (Wegovy) for metabolic dysfunction-associated steatohepatitis (MASH) 4Q 2025 the first oral GLP-1 ( oral formulation of Wegovy 25 mg ) for weight loss and weight loss plus secondary CV risk reduction 4Q 2025 Wegovy for heart failure with preserved ejection fraction and obesity October 2025 new indication for oral Rybelsus for secondary CV risk reduction 2025 Ozempic for T2DM and peripheral artery disease (PAD) Given the considerable continued growth expected in the GLP-1 pipeline, Prime Therapeutics (Prime) talented team of clinical experts actively monitors this emerging landscape
Diets high in refined carbohydrates and low in protein or fiber can cause blood glucose fluctuations that trigger hunger signals despite adequate caloric intake
